A clinical questing examination to verify vasculo-protective effect of azilsartan treatment in uncontrolled hypertensive patients with diabetes mellitus.

Trial Profile

A clinical questing examination to verify vasculo-protective effect of azilsartan treatment in uncontrolled hypertensive patients with diabetes mellitus.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 04 Apr 2017

At a glance

  • Drugs Azilsartan (Primary)
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 31 Mar 2017 Status changed from recruiting to discontinued.
    • 01 Apr 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network Japan.
    • 02 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top